<DOC>
	<DOCNO>NCT00191880</DOCNO>
	<brief_summary>Open-label trial Atomoxetine Evaluate Academic Outcome Children Ages 8-11 year Attention- Deficit/Hyperactivity Disorder</brief_summary>
	<brief_title>Open-Label Trial Atomoxetine Evaluate Academic Outcome Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients must ADHD , psychotropic medication naive outpatient least 8 year age 10 year age Visit 1 ( , yet reach 11 birthday ) year test complete child reach age 12 . Patients current past history Bipolar I II disorder , psychosis , autism , Asperger 's syndrome , pervasive developmental disorder , conduct disorder , seizure disorder serious suicidal risk exclude</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>